Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder
AssigneesTeva Pharmaceutical Industries Ltd., Yissum Research Development Company of the Hebrew University of Jerusalem
InventorsMitchell Shirvan, Meir Bialer
Life of this patent
Estimating the term…
Abstract
A method for the treatment of mania in bipolar disorder using derivatives of valproic acid and 2-valproenic acid amides having the following structures: wherein R1, R2, and R3 are independently the same or different and are hydrogen, a C1-C6 alkyl group, an aralkyl group, or an aryl group, and n is an integer which is greater than or equal to 0 and less than or equal to 3, or a compound containing a valproic or a 2-valproenic moiety, as well as pharmaceutical compositions comprising these derivatives or compounds.
Claims16
A method of treating the mania phase of bipolar disorder in a subject comprising administering to the subject a therapeutically effective amount of a derivative of a vaiproic acid amide or a 2-valproenic acid amide having one of the following structures:
- wherein R1, R2, and R3 are independently the same or different and are hydrogen, a C1-C6 alkyl group, an aralkyl group, or an aryl group, and n is an integer which is greater than or equal to 0 and less than or equal to 3, to thereby treat the mania phase of bipolar disorder.
Dependencies are inferred from the claim text.